Virtual webinar for a wide audience (targeted at HCPs who are involved in the patient journey of COVID-19). These HCPs will gain knowledge on the guidelines for the management of COVID-19 from all over the world and learning from the sharing of global experience. The speakers of these topics are independent clinicians from the USA, Denmark and Australia.

The webinar is organised by Gilead Sciences and executed by a 3rd party vendor (Elements). Host country is Switzerland. This is part 1 of a 3-series webinar.
 

• Module Management of hospitalized COVID-19 patients (April 13):
  • To evaluate the available data for remdesivir and understand its place and value in the treatment of patients with COVID-19
  • To explore differences in study design, interpretation of the data and the possible drivers of variability in study results
    
     
• Module Managing high-risk patients with COVID-19 (May 4):
  • To explore the latest evidence regarding patients at risk of severe COVID-19
  • To discuss expert case studies and identify best practice for managing patients with COVID-19 who are at risk of progressing to severe disease and are appropriate for treatment with remdesivir.